AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05304156 — intervention group
Intervention type: OTHER
Intervention: Biobanking blood and bone marrow specimens
Description: Interventions, procedures added for research purposes :~Blood Samples :~* Peripheral blood (20mL EDTA) (at Screening, pre-ICT Day 1, Day1 H8, Day 2, Day 3, Day 4 and Day of EOI evaluation~Bone Marrow samples :~* Biopsy at Screening and at EOI Evaluation~* Additional volume (2mL EDTA) on the Screening,2 and EOI Evaluation aspirations for single-cell analyses.~* Aspiration at D8 for Smears and 2 mL EDTA for single-cell analyses (instead of D15 standard care).
Study NCT05252221 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ATC Intervention
Description: The ATC intervention offers convenient access to specialty consultation for PCPs and offers patients direct access to addiction treatment in a non-stigmatized primary care setting
Study NCT04861246 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser
Description: The device will be used to do Laser treatment. To compare the therapeutic effect to laser treatment before and post treatment for 14 and 60 days.
Study NCT04861246 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ApolloVue® S100 Image System
Description: The device is an in vivo non-invasive optical coherence tomography and will be used to obtain OCT images before and after laser treatment of skin.
Study NCT04861246 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VISIA®
Description: The device is skin analysis system and will be used to obtain before and after images of laser treatment.
Study NCT05541159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TNO155
Description: Single oral dose of TNO155 on Day 1
Study NCT06351735 — intervention group
Intervention type: PROCEDURE
Intervention: Deep cervical lymph node-vein bypass surgery
Description: Deep cervical lymph node-vein bypass surgery, connecting deep cervical lymph node input lymphatic vessel
Study NCT04494087 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Explanatory video
Description: Links to explanatory videos handed out to patients to be watched at home after standard informed consent giving
Study NCT04494087 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Explanatory video
Description: Links to explanatory videos handed out to patients to be watched at home after standard informed consent giving
Study NCT04494087 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Informed consent form
Description: Links to a digital version of the informed consent form already discussed during the process of informed consent giving.
Study NCT04772287 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Toripalimab: 240mg, IV, q3w, 4 cycles in total; Platinum-containing dual-drug chemotherapy: The specific dose is based on the standard of the selected protocol, IV, q3w, a total of 4 cycles.
Study NCT04772287 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Toripalimab mimetic (placebo)
Description: Placebo: 240mg, IV, q3w, 4 cycles in total; Platinum-containing dual-drug chemotherapy: The specific dose is based on the standard of the selected protocol, IV, q3w, a total of 4 cycles.
Study NCT05408676 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electric stimulation therapy
Description: Transcutaneous electrical acupoint stimulation (TEAS) was achieved by an electrical neuromuscular stimulation device (JNR2; designed by the Department of Hand Surgery, Huashan Hospital, Fudan University, manufactured by Energy Conservation and Environment Protection Technology Company, Jiatong University, Shanghai,China)
Study NCT05408676 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: electric stimulation therapy
Description: Transcutaneous electrical acupoint stimulation (TEAS) was achieved by an electrical neuromuscular stimulation device (JNR2; designed by the Department of Hand Surgery, Huashan Hospital, Fudan University, manufactured by Energy Conservation and Environment Protection Technology Company, Jiatong University, Shanghai,China)
Study NCT05780099 — intervention group
Intervention type: OTHER
Intervention: Inpatient or Outpatient visit
Description: Patients will be seen and treated at the clinics like in the usual care
Study NCT05530889 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TEST Lens
Description: ACUVUE® Theravision® with Ketotifen
Study NCT05530889 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CONTROL Lens
Description: 1-DAY ACUVUE® MOIST.
Study NCT05625009 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Procedure/Surgery: Transversus Abdominis Plane Block (TAPB)
Description: Patients received TAPB postoperatively
Study NCT05625009 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Procedure/Surgery: Erector Spinae Plane Block (ESPB)
Description: Patients received ESPB postoperatively
Study NCT04812457 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hialucic
Description: A professional not present at the intervention (researcher 2) will proceed to carry out the postoperative cures 48 hours after the intervention. The bandage will be removed, the area will be washed with physiological saline and the drug will be applied according to the group to which it belongs. In the intervention group, an ointment with hyaluronic acid (hyalucic ®) will be used together with a non-stick dressing and a semi-compression bandage to prevent bleeding.
Study NCT04996888 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI based preoperative automatic reminder system
Description: the patients in the experimental group will be sent a message and a phone call by AI system on the day before colonoscopy, which will emphasize the importance of bowel preparation, the directions for use and side effects of purgatives, the proper food type, and the start time. The system is an non-invasive AI system.
Study NCT04812457 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Betadine gel
Description: A professional not present at the intervention (researcher 2) will proceed to carry out the postoperative cures 48 hours after the intervention. The bandage will be removed, the area will be washed with physiological saline and the drug will be applied according to the group to which it belongs. In the control group, Betadine Gel will be used together with a non-stick dressing and a semi-compression bandage to prevent bleeding.
Study NCT05021692 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-based support program for pregnant women with preeclampsia based on the Health Promotion Model
Description: support program
Study NCT06065410 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baseline
Description: Walking without any instruction or sound
Study NCT06087900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate continuous training (MICT)
Description: The participants received a moderate continuous training (MICT) program of walking or running a treadmill 3 days/week, 12 weeks. This training comprises 5 minutes of warm up at 50-55% of maximal heart rate, following by 50 minutes of exercise at 65-70% of maximal heart rate, and 5 minutes of cool down at 50-55% of maximal heart rate. The intensity of exercise increases to 70-75% of maximal heart rate at week 7-12.
Study NCT06087900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT)
Description: The participants received a 7x2 high intensity interval training (HIIT) program of walking or running a treadmill 3 days/week, 12 weeks. This training comprises training comprises 5 minutes of warm up at 50-55% of maximal heart rate, following by 28 minutes of exercise (2 minutes of high intensity at 85-90% of maximal heart rate interval with 2 minutes of low intensity at 50-55% of maximal heart rate 7 times), and 5 minutes of cool down at 50-55% of maximal heart rate. The intensity of exercise at high intensity increases to 90-95% of maximal heart rate at week 7-12.
Study NCT06087900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Description: The participants received Powerbreathe ® ClassicLight in this training program. The IMT group demonstrated the training 8 cycles of 30 breath, 5 days/week with progressive load 50% of maximal inspiratory pressure (MIP) at week 1-3, 60% of MIP at week 4-6, 70% of MIP at week 7-9, and 80% of MIP at week 10-12. Every first day of the week participants had to undergoing load adjustment at laboratory
Study NCT06087900 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control
Description: The CON group did not have any intervention but usual care.
Study NCT04498377 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: F-652
Description: IL-22 fusion protein administered intravenously
Study NCT04498377 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered intravenously
Study NCT06508606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK117
Description: AK117: 45mg/kg (D1, IVGTT, Q3W maintained for one year or until progression or intolerable toxicity occurred
Study NCT06508606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anti-EGFR
Description: anti-EGFR:initial dose 400mg/m2, subsequent doses of 250mg/m2, D1, QW) maintained for one year or until progression or intolerable toxicity occurred
Study NCT06508684 — intervention group
Intervention type: DRUG
Intervention: BTK inhibitor
Description: BTKi can refer to Orelabrutinib, Ibrutinib, Zanubrutinib, and Acalabrutinib
Study NCT04728594 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Proof
Description: Email
Study NCT04728594 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reframing
Description: Email
Study NCT04728594 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scarcity Message
Description: Email
Study NCT06065410 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intrinsic focus
Description: Walking focusing on ensuring equal step lengths and step durations on both sides and symmetry between both steps
Study NCT05857904 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CT-FFR
Description: CT -FFR(coronary computed tomography angiography drived fractional flow reserve derived) uses routine coronary computed tomography angiography (CTA) images and applies a specific algorithm to extract both anatomical and physiological information of the coronary arteries. By combining these two pieces of information, a fluid dynamics model of the coronary arteries can be established, allowing the calculation of FFR at any location of the coronary arteries.
Study NCT05857904 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: QFR
Description: Quantitative flow ratio (QFR) is a new method for evaluating the functional significance of coronary artery stenosis based on angiography. It can be used for real-time detection of hemodynamic abnormalities in the coronary arteries in the catheterization lab. Unlike traditional methods that require the use of pressure wires and vasodilators such as adenosine, the QFR examination process only requires routine coronary angiography. By reconstructing the three-dimensional structure of the blood vessels and analyzing the hemodynamics, the QFR can evaluate the fractional flow reserve (FFR) without the need for pressure wires and vasodilators.
Study NCT01196494 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: intraoperative colon lavage with primary anastomosis
Description: Patients with obstructive left-sided colonic cancer in wich treatment in one stage procedure is intraoperative colon lavage with primary anastomosis to avoid Hartamnn´s Procedure
Study NCT01196494 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: intraoperative colon lavage with primary anastomosis
Description: Patients with obstructive left-sided colonic cancer in wich treatment in one stage procedure is intraoperative colon lavage with primary anastomosis to avoid Hartamnn´s Procedure
Study NCT06065410 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: White noise
Description: Intrinsic focus accompanied by white noise
Study NCT06065410 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: environmental sound
Description: Intrinsic focus accompanied by environmental sound
Study NCT05737277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapral
Description: This will be a randomised, double-blind, placebo-controlled, parallel-arm trial, designed to evaluate the efficacy and safety of Bifidobacterium adolescentis PRL2019 in pediatric patients (> 4 years) with IBS (as assessed according to the Rome IV diagnostic criteria for IBS).~The study will include a 2-week screening period, and a 12-week placebo-controlled treatment period (Figure 1). After the screening phase, eligible patients will be randomly assigned to either 1 stick containing 20 Mld UFC of Bifidobacterium adolescentis PRL2019 (Gabapral, Pontenure, Italy), or the equivalent placebo once a day, in a 1:1 ratio, for 12 weeks. Study visits will be conducted every 4 weeks during the treatment period.
Study NCT05737277 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: This will be a randomised, double-blind, placebo-controlled, parallel-arm trial, designed to evaluate the efficacy and safety of Bifidobacterium adolescentis PRL2019 in pediatric patients (> 4 years) with IBS (as assessed according to the Rome IV diagnostic criteria for IBS).~The study will include a 2-week screening period, and a 12-week placebo-controlled treatment period (Figure 1). After the screening phase, eligible patients will be randomly assigned to either 1 stick containing 20 Mld UFC of Bifidobacterium adolescentis PRL2019 (Gabapral, Pontenure, Italy), or the equivalent placebo once a day, in a 1:1 ratio, for 12 weeks. Study visits will be conducted every 4 weeks during the treatment period
Study NCT04825990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg pembrolizumab every 3 weeks plus 300 mg olaparib twice a day (BID) every day starting from Day 1 of Cycle 1.
Study NCT06129110 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet Weight Loss
Description: Low calorie diet of meal replacement shakes
Study NCT05365737 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oral rinse
Description: Participants use mouthwasher for a given time.
Study NCT05365737 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Oral rinse
Description: Participants use mouthwasher for a given time.
Study NCT05365737 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Saliva harvest
Description: Non-stimulated saliva harvesting
Study NCT05365737 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saliva harvest
Description: Non-stimulated saliva harvesting
Study NCT06458231 — intervention group
Intervention type: DEVICE
Intervention: Blood Catheters
Description: Central line as a predisposing factor for Blood stream infection
Study NCT06209892 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Extended anticoagulation
Description: This study plan will extend the duration of rivaroxaban 20mg in the experimental group to 12 months. The regular anticoagulation group will take the drug for 6 months
Study NCT06182826 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Core Stability protocol
Description: 5 Minutes Warm up Hamstring stretch Back Extensor Stretch Hip Flexor Stretch Jumping Rope Stair Stepping Mountain Climbers Curl Up Side Planks Bird Dog Frequency: 3 sessions per week for six weeks. Time Duration: Approx. 30 to 45 minutes
Study NCT06182826 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Routine exercise therapy
Description: 5 Minutes Warm up Hamstring stretch Back Extensor Stretch Hip Flexor Stretch Jumping Rope Stair Stepping Mountain Climbers Frequency: 3 sessions per week for six weeks. Time Duration: Approx. 30 to 45 minutes
Study NCT06182826 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Routine exercise therapy
Description: 5 Minutes Warm up Hamstring stretch Back Extensor Stretch Hip Flexor Stretch Jumping Rope Stair Stepping Mountain Climbers Frequency: 3 sessions per week for six weeks. Time Duration: Approx. 30 to 45 minutes
Study NCT05007977 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZT-01 low dose
Description: Single subcutaneous (SC) injection of ZT-01 3 mg during hypoglycemic clamp
Study NCT04117425 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: biological collection
Description: Blood collection at each trimester of pregnancy, delivery and post partum visit or at medical interruption.~Collection of saliva at each trimester of pregnancy and post partum visit. Collection of cord blood and amniotic fluid at delivery or at medical interruption.
Study NCT06462079 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sacituzumab Govitecan
Description: Patients were treated with Sacituzumab Govitecan 10 mg/kg in 21-day treatment cycles with intravenous infusions on days 1 and 8 and continued until disease progression or unacceptable toxicity.
Study NCT06462079 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Radiotherapy was administered after the second infusion of Sacituzumab Govitecan, on day 9 after the start of this regimen. The radiotherapy regimen was: brain metastases at a dose of 60 Gy/20 doses. For lesions located adjacent to the brainstem and optic nerve, 54 Gy/20 doses were given. For patients with ≥5 lesions, whole-brain radiotherapy at 40 Gy/20 doses was synchronized with radiotherapy to localized brain metastases.
Study NCT06353620 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: High Density EEG recording
Description: Recording of resting state high density EEG (128 channels)
Study NCT05972343 — intervention group
Intervention type: DEVICE
Intervention: Cryoablation
Description: Takes place at single time point.
Study NCT05051306 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-load resistance exercise
Description: Subjects in high-load trial performed 4 sets per exercise, 8 repetitions with load of 85%-8RM with 90 sec of rest between sets.
Study NCT05051306 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low-load resistance exercise
Description: Subjects in low-load trial performed 4 sets per exercise, 15 repetitions with load of 45%-8RM with 90 sec of rest between sets.
Study NCT06154460 — intervention group
Intervention type: PROCEDURE
Intervention: Laterjet Surgery
Description: The laterjet procedure is an operation in which the coracoid process is transferred to the glenoid rim with a screw.
Study NCT06154460 — intervention group
Intervention type: PROCEDURE
Intervention: Reimplissage Surgery
Description: Reimplissagge operation, which means to fill, is an open procedure designed to limit the engagement of Hill-Sachs deformity by passing the infraspinatus into the Hill-Sachs defect.
Study NCT06154460 — intervention group
Intervention type: PROCEDURE
Intervention: Capsular Reconstruction
Description: Allografts or autografts are used for capsular reconstruction. In the procedure performed with capsular repair and grafts, the capsule is strengthened and stabilization is attempted
Study NCT05322759 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: aquatic exercises
Description: aquatic polymetric exercises for 30 min including hip abduction/adduction, knee flexion/extension, hip flexion/extension, holding pool from sides, bending forward and picking up objects, shoulder flexion/extension kangroo jumpes, jumping to sides.
Study NCT05322759 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aquatic exercises
Description: aquatic polymetric exercises for 30 min including hip abduction/adduction, knee flexion/extension, hip flexion/extension, holding pool from sides, bending forward and picking up objects, shoulder flexion/extension kangroo jumpes, jumping to sides.
Study NCT05322759 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: halliwick exercise programme
Description: Halliwick exercise programme for 30 min include sagittal rotations, transversal rotations, longitudnal rotations and combined rotations.
Study NCT05322759 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: halliwick exercise programme
Description: Halliwick exercise programme for 30 min include sagittal rotations, transversal rotations, longitudnal rotations and combined rotations.
Study NCT04782492 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: graft configuration in coronary artery bypass grafting
Description: Saphenous vein could be used as Y-composite graft or aortocoronary conduit during coronary artery bypass grafting
Study NCT04782492 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: graft configuration in coronary artery bypass grafting
Description: Saphenous vein could be used as Y-composite graft or aortocoronary conduit during coronary artery bypass grafting
Study NCT05289414 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency
Description: patients with diagnosis of cervicogenic headache will be subjected to radiofrequency treatment
Study NCT05289414 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Greater occipital nerve block
Description: patients with diagnosis of cervicogenic headache will be subjected to Greater occipital nerve block
Study NCT04861155 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SIVA-P3
Description: Digital cough recording: Participants receive a small, wearable data recorder, wear it during waking hours and keep it on the nightstand during sleep for 7x24 hours. The data is sent to a smartphone application, where a cough detection algorithm converts it into time-stamped cough events. Participants respond to questions on their smartphone once a day for additional context data. The cough events and context data are sent to a secure online database for further evaluation. For the first 24 hours, segments of audio data are sent to be able to validate the performance of the cough detection algorithm. Afterwards, only cough events and context data are sent from the participant's smartphone.